Teladoc Health (TDOC) shares clocked seven straight sessions of losses on Thursday, as the stock was 3.3% lower at $6.08.
The healthcare technology company lost nearly 16% in the preceding six sessions.
Looking at Seeking Alpha’s Quant Rating, TDOC has a Hold rating with a score of 2.7 out of 5. The company received B+ in the prospect of profitability, while it received D- in the growth factor.
Seeking Alpha analysts are positive and see the stock as a Buy.
Turing to the Wall Street, five analysts have given the stock a Buy or above rating. 22 gave the stock hold recommendation, while none gave Sell rating.
“TDOC’s recent acquisitions, including UpLift and Catapult Health, have not meaningfully offset declining user numbers or driven innovation,” pointed out a Seeking Alpha analysis.